Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
D000368:Aged; D001519:Behavior; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003289:Convalescence; D004877:Ergoloid Mesylates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008606:Mental Processes / Q000187:drug effects; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D010808:Physical Examination; D010919:Placebos; D011581:Psychological Tests
D010919:Placebos; D004877:Ergoloid Mesylates